|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2342233 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09744645.4 |
| Date of filing the European patent application | 2009-10-01 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-06-25 |
| (46) | Date of publication of the claims translation | 2014-10-27 |
| (86) | Number | PCT/EP2009/062787 |
| Date | 2009-10-01 |
| (87) | Number | WO 2010/037831 |
| Date | 2010-04-08 |
| (30) | Number | Date | Country code |
| 08305631 | 2008-10-01 | EP | |
| 136772 P | 2008-10-01 | US | |
| 173743 P | 2009-04-29 | US |
| (72) |
KLINGUER-HAMOUR, Christine, FR
GRENIR-CAUSSANEL, Véronique, FR
|
| (73) |
Pierre Fabre Médicament,
45, Place Abel Gance, 92100 Boulogne-Billancourt,
FR
|
| (74) |
Leonas Antanas KUČINSKAS,
Dr. Leono A. Kučinsko patentinių paslaugų firma, Kaštonų g. 5-7, LT-01107 Vilnius,
LT
|
| (54) | Anti CXCR4 antikūnai ir jų panaudojimas vėžio gydymui |
| ANTI CXCR4 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2015-09-25 | 7 | 162.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2016-10-01 |